CrossrefInfokarte
Tocilizumab in immune checkpoint inhibitor-induced myositis, myocarditis, and myasthenic syndrome: a rare case report and review of the literature
ARP Rheumatology · 2025-12-30 · 4 (4) · 300-304
DOI: 10.63032/rfpy6607 ↗Abstract
Kein Abstract verfügbar.
EUVIMED